Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03902587 · ClinicalTrials.gov registry record
Application of Cervical Elastography in Obstetrics
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 1,000
- Enrollment target
NCT03902587: Completed study, sponsored by NYU Langone Health.
NCT03902587 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03902587 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth. During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cervix technology. Each index will then be separated based on characteristics to create a nomogram for singletons, twins, and those with interventions already in place (i.e. cerclage and/or progesterone) at the time of their E-cervix assessment.
Interventions
- DEVICE Samsung's E-cervix technology
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2019-03-04 |
| Est. Completion | 2021-01-25 |
What the finished NCT03902587 record still lists
NCT03902587 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Samsung's E-cervix technology is the first listed.
NCT03902587 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03902587 about?
NCT03902587 is a clinical study titled "Application of Cervical Elastography in Obstetrics". The purpose of this study is to develop cervical elastography nomograms using Samsung's novel technology "E-cervix" and determine its ability to predict preterm birth. During each sonogram in which cervical lengths are measured, 5 additional cervical indices will be collected using Samsung's E-cerv...
What is the current status of trial NCT03902587?
This trial is currently completed. The enrollment target is 1,000 participants. The study started on 2019-03-04. Estimated completion is 2021-01-25.
What interventions are being tested in trial NCT03902587?
The interventions under investigation include: Samsung's E-cervix technology (DEVICE).
Who is sponsoring clinical trial NCT03902587?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI